SM
Sabby Management’s Actinium Pharmaceuticals ATNM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Hold |
0
| – | – | – | 76 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 91 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 85 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 78 |
|
|
2022
Q1 | – | Sell |
-73,366
| Closed | -$441K | – | 88 |
|
|
2021
Q4 | $441K | Buy |
73,366
+46,878
| +177% | +$282K | 0.06% | 69 |
|
|
2021
Q3 | $235K | Buy |
+26,488
| New | +$235K | 0.03% | 75 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 88 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 87 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 58 |
|
|
2020
Q3 | – | Sell |
-972,285
| Closed | -$342K | – | 71 |
|
|
2020
Q2 | $342K | Buy |
972,285
+350,445
| +56% | +$123K | 0.07% | 30 |
|
|
2020
Q1 | $121K | Sell |
621,840
-2,653,878
| -81% | -$516K | 0.05% | 35 |
|
|
2019
Q4 | $713K | Sell |
3,275,718
-5,521,791
| -63% | -$1.2M | 0.2% | 10 |
|
|
2019
Q3 | $2.02M | Buy |
8,797,509
+453,793
| +5% | +$104K | 1.09% | 3 |
|
|
2019
Q2 | $2.05M | Buy |
+8,343,716
| New | +$2.05M | 2.58% | 2 |
|
|
2018
Q2 | – | Sell |
-1,997,700
| Closed | -$729K | – | 93 |
|
|
2018
Q1 | $729K | Buy |
+1,997,700
| New | +$729K | 0.09% | 39 |
|
|
2017
Q4 | – | Sell |
-2,434,103
| Closed | -$1.4M | – | 84 |
|
|
2017
Q3 | $1.4M | Buy |
+2,434,103
| New | +$1.4M | 0.09% | 17 |
|
|
2017
Q1 | – | Sell |
-868,608
| Closed | -$760K | – | 135 |
|
|
2016
Q4 | $760K | Sell |
868,608
-514,021
| -37% | -$450K | 0.04% | 67 |
|
|
2016
Q3 | $1.87M | Buy |
+1,382,629
| New | +$1.87M | 0.07% | 34 |
|
|
2015
Q4 | – | Sell |
-68,427
| Closed | -$121K | – | 159 |
|
|
2015
Q3 | $121K | Buy |
+68,427
| New | +$121K | 0.01% | 187 |
|